Investors sentiment increased to 2.1 in Q2 2019. Its up 0.37, from 1.73 in 2019Q1. It improved, as 18 investors sold Spectrum Pharmaceuticals, Inc.

Source: Spectrum Pharmaceuticals, Inc. (SPPI) Analysts See $-0.31 EPS